Brexit the reason for Almac’s Dundalk move
Northern Irish based contract pharmaceutical development and manufacturing firm Almac has said its decision to buy a factory in the Republic of Irealnd was as a direct result of Brexit.
Last month the Craigavon-based firm announced a multi-million euro investment in a new Dundalk premises at the IDA Business Park which will create 100 jobs in the town.
It told a Commons Committee meeeting today that this decision was as a direct result of Britain’s decision to leave the EU, saying its customers needed to have a presence in the EU for regulatory reasons.
According to the BBC, Almac said it could face dual processes such as having to certify a product both in NI and Ireland so it can be sold in the EU.
Almac has also warned it may have to move some work to the Republic of Ireland from Northern Ireland, depending on post-Brexit arrangements.
Company director Colin Hayburn described the Irish facility, in Dundalk, as “a safety net”.
He said it would have “minimal” operational requirements in the short term, but could be ramped up when needed.
Mr Hayburn added that if EU-UK regulatory equivalence was achieved as part of Brexit, Almac “should be fine” but said that if that equivalence is not achieved it would be a “difficult situation.”